New Zealand community pharmacists' views of their roles in meeting medicine-related needs for people with mental illness

Crump, Keith; Boo, Guobin; Liew, Fung Shin; Olivier, Tracy; So, C. S.C.; Sung, Justin; Wong, Chi Hang; Shaw, John; Wheeler, Amanda

doi:10.1016/j.sapharm.2010.03.006

Cited by 31 publications

(30 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thirdly, statin users were more likely to have a regular pharmacy than OC users (97% versus 75%, P <0.0001), and this would lead statin users to interact more with their pharmacists and be more likely to ask them for an additional supply if they ran out between doctors’ appointments. In addition, pharmacists would empathically dispense when they have the medication history of the patient, which is most likely to be available for regular customers 32,33. Finally, OC users were more likely to have full-time jobs ( P <0.0001) when compared with statin users, so may have more difficulty in organizing a doctor’s appointment 34.…”

Section: Discussionmentioning

confidence: 99%

Patient attitudes towards a new role for pharmacists: continued dispensing

Abukres¹,

Hoti²,

Hughes³

2014

PPA

View full text Add to dashboard Cite

BackgroundIn Australia, “continued dispensing” (CD) is a new model for supply of prescription medications. Under specific circumstances, community pharmacists are allowed to dispense a further one month supply of prescription only medications without a valid prescription. It allows continuation and treatment adherence when patients run out of statin and/or oral contraceptive (OC) medications, when it is not practical or they fail to plan accordingly to get a new prescription.ObjectiveThe aim of this study was to explore patient attitudes towards a CD model, including any perceived concerns or associated risks with CD prior to its introduction.MethodsAn Australia-wide computer-assisted telephone interview survey of statin and OC users aged 18 years or older was conducted in July 2013 prior to implementation of the CD model. A telephone number list was generated via a random number generation function based on a broad breakdown of the Australian population as outlined in the June 2013 Australian Bureau of Statistics data. The sample target for the survey was 300, consisting of 150 statin users and 150 OC users.ResultsThere were a total of 301 respondents, comprising 151 statin users and 150 OC users. Approximately 37% of all respondents had experienced running out of their medications in the past 12 months, of whom 35.4% had temporarily stopped treatment and 33.6% requested their medication from a pharmacist without a valid prescription. OC users were more likely to run out of their medications (P=0.021). The majority of respondents had a regular pharmacy (86%) and therefore would be eligible for CD in the future. The majority of those surveyed had no concerns about CD or perceived it as posing no risks. Concerns raised included consultation privacy and the pharmacist’s lack of access to their medical records.ConclusionAustralian users of statin and OC medications showed a high level of support for CD. Given that a significant proportion of patients temporarily stopped treatment when they ran out of medications and had no valid prescription, implementation of CD may alleviate the negative consequences of therapy interruption in statin and OC users in the short term. Longer-term solutions and opportunities to expand CD require further exploration.

show abstract

Section: Discussionmentioning

confidence: 99%

Patient attitudes towards a new role for pharmacists: continued dispensing

Abukres¹,

Hoti²,

Hughes³

2014

PPA

View full text Add to dashboard Cite

show abstract

“…First, it pertains to the community pharmacists' perceptions of their actual practices toward individuals with depression. It adds to the literature on this issue [27][28][29][30][31][32][33][34]36,62,67,68 and provides new insights into the challenges for practice. Second, this study was based on focus groups carried out in several regions of Quebec province with pharmacists with different socio-professional characteristics.…”

Section: Strengths and Limitationsmentioning

confidence: 99%

“…Providing pharmaceutical care to patients treated for depression is perceived as more difficult, compared to doing so to patients with other chronic diseases. [27][28][29] Pharmacists see significant lacks of time, [27][28][29][30][31][32][33][34] privacy, [27][28][29][30]32,34 information about patient diagnosis and relevant history, [27][28][29]31,33 training on mental health issues [27][28][29][30]35,36 and pharmaceutical care, 34 and lack of collaboration with physicians 29,31,[33][34][35] as the main barriers to the provision of pharmaceutical care to patients having an ADT. Also noteworthy are the pharmacists' uneasiness when providing this type of patient-centered intervention to patients with depression 27,29,33,35,37 and their perception that patients may be reluctant to discuss depression.…”

Section: Introductionmentioning

confidence: 99%

Perspective of community pharmacists on their practice with patients who have an antidepressant drug treatment: Findings from a focus group study

Guillaumie

Moisan

Grégoire

et al. 2015

Research in Social and Administrative Pharmacy

View full text Add to dashboard Cite

“…The research in this area to date has not yet provided adequate understanding of this complex phenomenon and primarily focuses on examining stigma. Thus far, consumer experiences with community pharmacy services, 9,10 pharmacists' experiences in serving people with lived experience of mental illness [11][12][13][14][15][16][17][18][19][20][21][22][23] and students' experiences primarily outside of the Canadian context [24][25][26][27][28][29] have been explored.…”

Section: Introductionmentioning

confidence: 99%